ADVERTISEMENT

Philip L. Cyr, MPH

Viewpoint

Beyond the Current Standard of Care for Pediatric ADHD: A New Era of Digital Therapeutics

03/20/2019

Madison Preib , MPH;

Philip L. Cyr , MPH;

Robert L. Findling , MBA, MD;

As the most common neurodevelopment disorder of childhood, attention-deficit/hyperactivity disorder (ADHD) places a significant burden on the US health care system.1-5 In today’s changing medical climate, there is growing pressure to improve...

As the most common neurodevelopment disorder of childhood, attention-deficit/hyperactivity disorder (ADHD) places a significant burden on the US health care system.1-5 In today’s changing medical climate, there is growing pressure to improve...

As the most common...

03/20/2019

First Report Managed Care

Pharma Insights

Economic Assessment of Novel Gene and Cellular Therapies: Beyond Traditional Modeling

04/17/2018

Philip L. Cyr , MPH;

Larry Blandford , PharmD;

Various forms of decision health analytic modeling have been used for the last 3 decades to assess potential health economic impact of new therapies. As initial gene and cellular therapies come to market, debate is...

Various forms of decision health analytic modeling have been used for the last 3 decades to assess potential health economic impact of new therapies. As initial gene and cellular therapies come to market, debate is...

...

04/17/2018

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

Derm Week

November 13 ⁠–⁠ November 16

Dermatology Week

November 13 ⁠–⁠ November 16

November 14 ⁠–⁠ November 15

November 23 ⁠–⁠ November 24

December 4 ⁠–⁠ December 5

Great Debates & Updates in Diabetic Foot

December 6 ⁠–⁠ December 7

December 9 ⁠–⁠ December 11

December 9 ⁠–⁠ December 11

December 12 ⁠–⁠ December 13

December 14 ⁠–⁠ December 15

See Full Calendar

Advertisement

Advertisement